Rizatriptan Benzoate

CAS 145202-66-0 20 API suppliersSmall Molecule

Overview

Rizatriptan Benzoate is a selective serotonin 5-HT1B/1D receptor agonist used to treat migraine headaches. It works by narrowing blood vessels in the brain and reducing substances in the body that trigger headache pain, sensitivity to light and sound, and other migraine symptoms.

API suppliers (21)

Suppliers of Rizatriptan Benzoate evidenced by a US FDA Type II Drug Master File or an EU Certificate of Suitability (CEP). Sources: FDA DMF list, EDQM certification database.

Where these suppliers are
India15Taiwan1USA1China1Spain1

Country recorded for 19 of 21 suppliers.

13 of 21 hold a GMP certificate on record in the EU or UK registers · 1 holds a European CEP for this substance

Therapeutic areas

NeurologyPain Management
Verified Supplier Partner

Do you supply Rizatriptan Benzoate? Get in front of buyers actively sourcing it.

We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.

No cost to enquire · we only reach out with a fit.

Ready to Accelerate Your
Discovery Workflow?

Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.